BEIJING: Chinese and Pakistani companies have signed a strategic agreement for establishment of a Cancer Precision Medical Laboratory.
According to the agreement, Beijing Anlong Gene Medicine Technology Co., Ltd. and Life Rehealth Technology Pakistan Co., Ltd., will jointly establish a cancer precision medical laboratory.
Under the framework, the two companies will jointly carry out exploration and research on cancer medical treatment, and the Chinese company will also share its existing medical technologies with Pakistan.
Dr. Ahmed Waqas, CEO of Pakistan Life Rehealth Technology Co., Ltd. has been active in China-Pakistan medical cooperation for a long time. In an exclusive interview, he told Economic Daily-China Economic Net that the incidence of cancer in Pakistan is very high, especially lung cancer and liver cancer.
However, due to Pakistan’s current medical standards and sanitary conditions, patients cannot be well treated. Therefore, China-Pakistan cooperation in this field is very necessary and will bring great benefits to Pakistan.When asked why he chose to cooperate with China, Dr. Waqas said that the medical field is very important and requires deep friendship and trust between the two sides. “China and Pakistan have always been known as ‘brothers’, and the Pakistani people trust China.
Therefore, in medical care, the first thing we think of for cooperation in the field must be our good brother.”
In addition, Dr. Waqas said, “China’s rapid development in the medical field in recent years is obvious to all, and the technology in cancer medicine is relatively mature. Therefore, we believe that through this cooperation, China can use this platform to help Pakistan import more mature medical technology for treatment of patients in Pakistan.” – Agencies
